Hims & Hers Health (HIMS) Gross Profit Growth (3y) (2023 - 2026)
Hims & Hers Health (HIMS) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.95% |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 37.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.26% |
| Dec 31, 2025 | 49.75% |
| Sep 30, 2025 | 56.90% |
| Jun 30, 2025 | 68.38% |
| Mar 31, 2025 | 79.27% |
| Dec 31, 2024 | 81.22% |
| Sep 30, 2024 | 79.60% |
| Jun 30, 2024 | 75.74% |
| Mar 31, 2024 | 78.55% |
| Dec 31, 2023 | 85.65% |
| Sep 30, 2023 | 81.60% |
| Jun 30, 2023 | 87.87% |
| Mar 31, 2023 | 95.23% |